SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Guggenheim reiterates Buy on Johnson & Johnson, $287 target

Guggenheim reaffirmed a Buy rating on Johnson & Johnson and set a $287 price target.

JNJ